APA

Molina R., Jo J., Filella X., Zanón G., Farrus B., Muñoz M., Latre M. L., Pahisa J., Velasco M., Fernandez P., Estapé J. & Ballesta A. M. (19990928). C-erbB-2, CEA and CA 15.3 serum levels in the early diagnosis of recurrence of breast cancer patients. : Anticancer research.

Chicago

Molina R, Jo J, Filella X, Zanón G, Farrus B, Muñoz M, Latre M L, Pahisa J, Velasco M, Fernandez P, Estapé J and Ballesta A M. 19990928. C-erbB-2, CEA and CA 15.3 serum levels in the early diagnosis of recurrence of breast cancer patients. : Anticancer research.

Harvard

Molina R., Jo J., Filella X., Zanón G., Farrus B., Muñoz M., Latre M. L., Pahisa J., Velasco M., Fernandez P., Estapé J. and Ballesta A. M. (19990928). C-erbB-2, CEA and CA 15.3 serum levels in the early diagnosis of recurrence of breast cancer patients. : Anticancer research.

MLA

Molina R, Jo J, Filella X, Zanón G, Farrus B, Muñoz M, Latre M L, Pahisa J, Velasco M, Fernandez P, Estapé J and Ballesta A M. C-erbB-2, CEA and CA 15.3 serum levels in the early diagnosis of recurrence of breast cancer patients. : Anticancer research. 19990928.